drugset / Trial / NCT00002751
Monoclonal Antibody Therapy in Treating Patients With Brain Metastases
Treatment
Summary
RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Phase I/II trial to study the effectiveness of monoclonal antibody therapy in treating patients who have brain metastases.
Timeline
- Start
- 1989-07
- Primary completion
- —
- Completion
- 2004-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Me1-14 F(ab')2 | Monoclonal antibody | — | Intrathecal |